Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

NCT05296304

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites) Rockville Centre, New York, United States
View Trial Details
Recruiting

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

NCT03666000

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +27 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute Emory University Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Recruiting

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

NCT05180097

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • Shoalhaven Cancer Care Centre Nowra, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
View all 18 locations
View Trial Details
Recruiting

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT05633615

Conditions
Diffuse Large B-cell Lymphoma, Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 87 locations
View Trial Details
Recruiting

Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma

NCT06829771

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Maanshan People's Hospital Ma’anshan, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
View all 25 locations
View Trial Details

Related conditions